Target intelligence / Profile preview

Procollagen hydroxylase (P4H)

Target
P4H
Molecular classification
Enzyme, Oxidoreductase, 2-oxoglutarate-dependent dioxygenase, Iron-dependent hydroxylase
01

Overview

Procollagen hydroxylases are a group of 2-oxoglutarate-dependent dioxygenases essential for the post-translational modification of collagen. This group primarily includes prolyl 4-hydroxylase (P4H), prolyl 3-hydroxylase (P3H), and lysyl hydroxylase (LH/PLOD), which catalyze the hydroxylation of specific proline and lysine residues within the collagen polypeptide chains (Myllyharju, 2003). These modifications are crucial for the stability of the collagen triple helix and the subsequent formation of covalent cross-links that provide tensile strength to the extracellular matrix (Gorres & Raines, 2010). The enzymes require ferrous iron, molecular oxygen, 2-oxoglutarate, and ascorbic acid as essential cofactors for their catalytic activity (UniProt). Dysregulation of these enzymes is strongly linked to fibrotic disorders, such as pulmonary and hepatic fibrosis, where excessive collagen deposition leads to organ dysfunction (Rappu et al., 2019). In oncology, these enzymes are often upregulated, promoting a stiffened tumor stroma that facilitates cancer cell invasion and metastasis (Yamauchi & Sricholpech, 2012). Therapeutic strategies focus on small-molecule inhibitors that compete with the 2-oxoglutarate cofactor or iron to reduce collagen stability and accumulation in pathological states.

Other names
Collagen synthesis dioxygenasesProcollagen-proline, 2-oxoglutarate 4-dioxygenaseProcollagen-lysine, 2-oxoglutarate 5-dioxygenaseCollagen prolyl 4-hydroxylaseLysyl hydroxylasePLOD2-oxoglutarate-dependent collagen hydroxylases
02

Mechanism of action

Competitive inhibition of the 2-oxoglutarate binding site or chelation of the active-site ferrous iron (Fe2+), thereby preventing the hydroxylation of prolyl or lysyl residues required for collagen stability.

03

Biological functions

Collagen biosynthesisPost-translational modificationExtracellular matrix organizationProtein folding
04

Disease associations

FibrosisCancerScurvyEhlers-Danlos syndromeOsteogenesis imperfecta
05

Safety considerations

Impaired wound healingOff-target inhibition of HIF prolyl hydroxylasesSkeletal fragilityVascular complications
06

Interacting drugs

Ethyl 3,4-dihydroxybenzoate

5 more in the full profile.

07

Biomarkers

HydroxyprolineProcollagen type I N-terminal propeptide (PINP)Procollagen type III N-terminal propeptide (PIIINP)Pyridinoline

Beyond the preview

Go deeper on Procollagen hydroxylase (P4H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Procollagen hydroxylase (P4H).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call